Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors
<p dir="ltr">Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent one type of new-generation type 2 diabetes (T2DM) drug treatment. The mechanism of action of an SGLT2 inhibitor (SGLT2i) in treating T2DM depends on lowering blood glucose levels effectively via increasing the...
محفوظ في:
| المؤلف الرئيسي: | Najlaa A. Al Thani (17788493) (author) |
|---|---|
| مؤلفون آخرون: | Maram Hasan (6672440) (author), Huseyin C. Yalcin (6695099) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Hemorrhagic ascites as a complication of heart failure: A case report and review of the literature
حسب: Shahem Abbarh (17945564)
منشور في: (2022) -
Implications of the medication regimen complexity index score on hospital readmissions in elderly patients with heart failure: a retrospective cohort study
حسب: Asmaa Abdelbary (16400059)
منشور في: (2023) -
Chronic anemia complicated by cardiac failure, pulmonary hypertension, and pericardial effusion: a case report
حسب: Muhammad Yousaf (754345)
منشور في: (2023) -
“Double-Lumen Valve-Controlled Intra-Operative Pyeloplasty Stent (VIPs)”: A New Technology for Post-Pyeloplasty Stenting – Proof of Concept Study in a Preclinical Large Animal Model
حسب: Tariq Osman Abbas (18148378)
منشور في: (2020) -
Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample
حسب: Menatalla Mekhaimar (14103708)
منشور في: (2020)